VEGFA Rekombinanter Antikörper

VEGFA Rekombinant Antikörper für WB, IF/ICC, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IF/ICC, ELISA

Konjugation

Unkonjugiert

Publikationen(3)

CloneNo.

7H10

Kat-Nr. : 81323-2-RR

Synonyme

VEGF, 7H10, L-VEGF, N-VEGF, Vascular Endothelial Growth Factor



Geprüfte Anwendungen

Erfolgreiche Detektion in WBMCF-7-Zellen, A431-Zellen, HUVEC-Zellen, MDA-MB-231-Zellen, RAW 264.7-Zellen, T-47D-Zellen
Erfolgreiche Detektion in IF/ICCHeLa-Zellen, MCF-7-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:5000-1:50000
Immunfluoreszenz (IF)/ICCIF/ICC : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

WBSee 3 publications below
IFSee 1 publications below

Produktinformation

81323-2-RR bindet in WB, IF/ICC, ELISA VEGFA und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
In Publikationen genannte Reaktivitäthuman, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen VEGFA fusion protein Ag13500
Vollständiger Name vascular endothelial growth factor A
Berechnetes Molekulargewicht 412 aa, 46 kDa
Beobachtetes Molekulargewicht40 kDa
GenBank-ZugangsnummerBC065522
Gene symbol VEGFA
Gene ID (NCBI) 7422
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

VEGFA, also named as VEGF or VPF, belongs to the PDGF/VEGF growth factor family. It is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. VEGFA induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. It binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. Defects in VEGFA are associated with microvascular complications of diabetes type 1 (MVCD1). VEGFA has 17 isoforms with MW from 16 to 45 kDa. Some isoforms have homodimer forms (e.g.; VEGFA189 38 kDa or VEFGA110 34 kDa). VEGF-A exists in at least seven homodimeric isoforms. The monomers consist of 121, 145, 148, 165, 183, 189, or 206 amino acids (PMID:15602010 ).

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
WB protocol for VEGFA antibody 81323-2-RRProtokoll herunterladen
IF protocol for VEGFA antibody 81323-2-RRProtokoll herunterladen
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Oncol Rep

Triple‑negative breast cancer cell‑derived piR‑31115 promotes the proliferation and migration of endothelial cells via METTL3‑mediated m6A modification of YAP1

Authors - Shan-Mei Du
mouseWB

Apoptosis

CCDC134 enhances ovarian reserve function and angiogenesis by directly interacting with INHA in a mouse model of premature ovarian insufficiency

Authors - Xiangrong Cui
mouse,humanWB,IF

Biomaterials

Chiral nanoassembly remodels tumor microenvironment through non-oxygen-dependent depletion lactate for effective photodynamic immunotherapy

Authors - Xuan Zhang